3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Hemorrhage
12
Neoplasms
7
Leiomyoma
6
Breast Neoplasms
6
Thrombocytopenia
3
Postoperative Hemorrhage
3
Meningioma
3
Hematologic Neoplasms
3
Urinary Bladder Neoplasms
2
Seroma
2
Seizures
2
Prostatic Neoplasms
2
Myofibroma
2
Menorrhagia
2
Brain Neoplasms
2
Bone Neoplasms
2
Blood Loss, Surgical
2
Wrist Fractures
1
Urologic Diseases
1
Urinary Tract Infections
1
Urinary Retention
1
Thromboembolism
1
Stomach Neoplasms
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Skin Neoplasms
1
Sepsis
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
9
Ciprofloxacin
7
gamma-Globulins
3
Voriconazole
3
Fluconazole
3
Daptomycin
3
Antibiotic Prophylaxis
3
Amoxicillin-Potassium Clavulanate Combination
3
Whole-Body Irradiation
2
Vancomycin
2
Trimethoprim
2
Sulfamethoxazole
2
Saline Solution
2
Ribavirin
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Melphalan
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Fosfomycin
2
Ethanol
2
Cyclophosphamide
2
Cefazolin
2
Caspofungin
2
ziprasidone
1
tocilizumab
1
telavancin
1
telaprevir
1
talquetamab
1
soybean oil, phospholipid emulsion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Infections
×
Tranexamic Acid
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled